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The aim of this study was to evaluate the effects of moderate aerobic exercise training on sleep, depression, cortisol, and markers
of immune function in patients with chronic primary insomnia. Twenty-one sedentary participants (16 women aged 44.7 ± 9
years) with chronic primary insomnia completed a 4-month intervention of moderate aerobic exercise. Compared with baseline,
polysomnographic data showed improvements following exercise training. Also observed were reductions in depression symptoms
and plasma cortisol. Immunologic assays revealed a significant increase in plasma apolipoprotein A (140.9 ± 22 to 151.2 ± 22mg/dL)
and decreases in CD4 (915.6 ± 361 to 789.6 ± 310mm3) and CD8 (532.4 ± 259 to 435.7 ± 204mm3). Decreases in cortisol were
significantly correlated with increases in total sleep time (𝑟 = −0.51) and REM sleep (𝑟 = −0.52). In summary, long-termmoderate
aerobic exercise training improved sleep, reduced depression and cortisol, and promoted significant changes in immunologic
variables.
1. Introduction
Chronic primary insomnia is a prevalent condition that
affects 10–15%of the adult population, predominantlywomen
[1]. Insomnia is particularly prevalent later in life, affecting
approximately 12–25% of healthy seniors, and the prevalence
is even higher among older adults with coexisting medical or
psychiatric disorders [2].
Insomnia is often associated with occupational and psy-
chosocial impairments, such as daytime fatigue, mood dis-
turbances, cognitive deficits, and poor quality of life [3].
Some evidence suggests that sleep disturbances in depressed
individuals are associated with impaired immune function
[4, 5]; lower NK cell activity [6] and significantly lower levels
of immune cells (CD3+, CD4+, and CD8+) [7] are associated
with chronic insomnia.
Although the most common treatment for insomnia is
pharmacotherapy, this type of treatment is associated with
mortality [8] and other negative risk factors. Thus, non-
pharmacological interventions have been suggested for the
treatment of insomnia. Cognitive and behavioral therapies
have been themost commonnonpharmacological treatments
[9, 10]. However, considering the high cost of maintaining
these therapies, new nonpharmacological alternatives have
been suggested, including regular exercise [11].
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Acute [12] and chronic aerobic exercise [13–15] stud-
ies have demonstrated significant reductions in insomnia.
Among the positive effects of aerobic exercise on health is
the promotion of immune function [16]. The objective of the
present study was to evaluate the effects of aerobic exercise on
sleep, depression symptoms, immune function, and cortisol
levels among patients with chronic primary insomnia.
2. Methods
The study was approved by the University Human Research
Ethics Committee and conformed to the principles out-
lined in the Declaration of Helsinki. The participants were
recruited through advertisements in newspapers, magazines,
and radio shows.
2.1. Screening. Interested prospective participants contacted
the laboratory and were initially screened in a phone inter-
view. The initial inclusion criteria included being between
30 and 55 years old; having insomnia complaints for longer
than 6 months; and having at least one complaint of daytime
impairment resulting from insomnia (i.e., mood, cogni-
tion, or perception of fatigue). The initial exclusion criteria
included the use of medication or psychotherapeutic drugs
for insomnia or other psychiatric disorders, shiftwork, and
exercising ≥1 day per week.
Prospective participants who passed the phone screen
were invited to the laboratory for further orientation to the
study and screening. During the visit, the prospective partic-
ipants signed a written informed consent form approved by
the ethics committee.
Furthermedical screening included establishing a clinical
diagnosis of primary insomnia according to the DSM-IV
[17] and the American Academy of Sleep Medicine [18]
for a period longer than 6 months. Additional exclusion
criteria included blood tests contraindicating participation
in exercise, having major depression (i.e., a Beck Depression
Inventory score >20; [19], having an apnea-hypopnea index
(AHI) >15, having a periodic leg movement index (PLMI)
>15, and being a shift worker or all-night worker).
The participants received a clinical consultation and an
electrocardiogram at rest and under maximal stress during
cardiopulmonary exercise testing (CPET). The CPET was
performed on a treadmill (Life Fitness 9500 HR) with an
initial velocity of 4 km/h, increasing the speed by 0.5 km/h
each minute until voluntary exhaustion. Breath-by-breath
assessments were collected using a metabolic system (Quark
PFT4, Rome, Italy). The highest V̇O
2
value obtained during
the last 20 seconds of the test was considered to be the peak
oxygen uptake (V̇O
2
peak). The ventilatory threshold (VT
1
)
was estimated by inspecting the inflection point of V̇CO
2
with respect to V̇O
2
(modified V-slope) [20, 21]. A certificate
attesting to the patient’s ability to participate in the exercise
protocol was provided by his or her physician and served as
the final requirement for participation in the study.
2.2. Exercise Training. Following screening, the participants
performed the exercise training regimen for 4 months.
Exercise was performed 3 days per week for 50 continuous
minutes per bout at the VT
1
[20, 21], established during the
CPET.The timing of the exercise was randomized to occur in
the morning (10:00 ± 1 h) or in the evening (18:00 ± 1 h).
2.3. Polysomnographic Measures. The participants under-
went polysomnographic (PSG) recording at the Sleep Insti-
tute before and after the exercise training. For the preinter-
vention assessment, PSG recording was performed over 2
nights.The first night served as an adaption night; 48 hr later,
the participants returned for another night of PSG recording.
The posttraining PSG assessment occurred at least 30 hours
after the last exercise session. The participants arrived at
the sleep laboratory at 21:00; the PSG recording started and
finished according to each volunteer’s habitual sleep schedule.
The digital system EMBLA was used (EMBLA S7000, Embla
Systems Inc., CO, USA). The measured variables included
total sleep time (TST), sleep efficiency (the ratio between
total sleep time and total recorded time multiplied by 100),
sleep onset latency, waking after sleep onset, arousals, sleep
stages (I, II, III, and IV of NREM sleep and REM sleep), and
the latencies for each sleep stage, including Stage 1, Stage 2,
Stages 3 and 4, and REM. The apnea-hypopnea index (AHI)
and periodic leg movements (PLM) were alsomeasured. Two
researchers who were blinded to the study design performed
the staging and analyzed the PSG events using international
criteria [22–24].
2.4. Questionnaires and Blood Draw. Approximately twenty-
four hours after the PSG assessment, the subjects arrived
in the laboratory at 9 a.m. They completed the Pittsburgh
Sleep Quality Index [25] and Beck Depression Inventory [19].
At approximately 10-11 a.m. preprandial venous blood was
drawn from the medial cubital vein.
2.5. Immunologic Assays
2.5.1. Immunological Measures. Total leukocyte and sub-
group cell counts were determined using an automated
hematology analyzer (Advia 120, Siemens). CD4 and CD8
populations were determined by flow cytometry using the
CD3/CD4 or CD3/CD8 expression in the cell surface (FAC-
SCalibur, Becton Dickison, San Jose, CA, USA).
2.5.2. Cortisol and Apolipoprotein. Plasma cortisol concen-
trations were determined using a chemiluminescence immu-
noassay (Unicell DXI, Beckman Coulter, Fullerton, CA,
USA), CV%within assay: 4.4. CRP was determined by neph-
elometry (Image 800, Beckman Coulter), CV% within assay:
5.0. Apolipoprotein A (ApoA) and apolipoprotein B (ApoB)
were measured using nephelometry (Image 800, Beckman
Colter), CV% within assay: 4.0.
2.6. Statistical Analysis. The program STATISTICA (Statsoft,
Inc., version 7.0) was used for data analysis. We tested
normality by Shapiro Wilk’s test. For normally distributed
data we used Student’s paired 𝑡-test (to compare the pre- and
postexercise measures) and for data that violated normality
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267 patients assessed for eligibility
229 excluded 
47 were excluded for having reported a previous 
diagnosis of depression 
20 for having reported a diagnosis of other 
psychiatric disorders
39 for practicing systematic physical exercise 
16 for working in shifts
15 for an apnea-hypopnea index or a periodic leg 
70 for having reported the regular use of medication 
for insomnia
22 for not presenting evidence of insomnia at the 
time of evaluation.
Screening: 38 participants
17 participants drop out
Baseline: 21 participants 
After exercise: 21
participants
movement index >15
Figure 1: Participant flowchart.
Table 1: Physiological parameters.
Variable Baseline (𝑁 = 21) After exercise (𝑁 = 21) 𝑃
BMI (kg/m2) 24.7 ± 5 24.6 ± 5 ns
VO2peak (mL/kg/min) 28.4 ± 7 30.3 ± 6 ns
Speed VT1 (km/h) 5.3 ± 1 6.1 ± 1 <.001
Wilcoxonmatched pairs test, significant results, 𝑃 < .05; data are expressed as mean ± SD. VO2peak: peak oxygen consumption; VT1: first ventilatory threshold.
we usedWilcoxon matched pairs test. Spearman’s correlation
coefficient was performed to assess associations between
immune system variables and sleep data (after exercise-
baseline means). The data are expressed as the mean ± SD.
The level of statistical significance was set at 𝑃 < .05.
3. Results
3.1. Recruitment, Participant Attrition, and Adherence to the
Exercise Protocol. Twohundred sixty-seven people contacted
the researchers by telephone or email with interest in partic-
ipating in the study. Of this total, 229 were excluded because
they did not meet the inclusion criteria (Figure 1). Thirty-
eight participants (29 women) passed the initial screening.
However, before beginning the exercise training protocol, 3
men and 5womenwithdrew from the study during the prein-
tervention period.
Thus, the exercise protocol began with a sample of 30
participants. However during the first month of the study 11
participants drop out. Of these, 9 (30%) dropped out because
of problems with the program schedule, which could not be
changed during the study. As a result, the final sample size
was 21. These 21 participants exhibited good adherence to
the study protocol (>90%) based on their class attendance
and the percentage of the exercise time they spent within the
prescribed intensity (90%).
3.2. Physiological Parameters. Significant increase in speed in
VT
1
(5.3±1 to 6.1±1 km/h,𝑃 < .001) was found after exercise
training (Table 1).
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Table 2: Polysomnography variables on the baseline and after exercise.
Variable Baseline (𝑁 = 21) After exercise (𝑁 = 21) 𝑃
TST (hours) 5.7 ± 0.8 6.1 ± 0.5 .02
∗SOL (min) 22.5 ± 23 8.6 ± 8 <.001
LREM (min) 100.4 ± 38 76.0 ± 43 .01
SE (%) 82.2 ± 10 88.9 ± 8 .006
∗WASO (min) 53.2 ± 49 38.2 ± 25 .03
Arousals (events/hour) 17.8 ± 23 15.6 ± 13 ns
Stage 1 (%) 3.9 ± 2 3.9 ± 3 ns
∗Stage 2 (%) 56.7 ± 7 54.5 ± 8 ns
Stage 3 (%) 4.6 ± 2 5.1 ± 2 ns
Stage 4 (%) 15.3 ± 5 14.5 ± 6 ns
REM sleep (%) 19.4 ± 6 21.9 ± 6 .04
∗Latency of Stage 1 (min) 80.6 ± 89 38. 9 ± 77 ns
∗Latency of Stage 2 (min) 23.6 ± 23 10.5 ± 11 .01
∗Latency of Stages 3 and 4 (min) 55.6 ± 51 33.7 ± 18 .04
∗AHI (events/hour) 9.7 ± 9 8.1 ± 9 ns
∗PLM (events/hour) 2.0 ± 4 2.2 ± 5 ns
Paired Student’s 𝑡-test or ∗Wilcoxon matched pairs test, significant results, 𝑃 < .05; data are expressed as mean ± SD. TST: total sleep time; SE: sleep efficiency;
SOL: sleep onset latency; REM: rapid eye movements; LREM: REM sleep latency; TWT: total wake time; WASO: wake time after sleep onset; AHI: apnea
hypopnea index; PLM: periodic leg movements.
3.3. Polysomnography. Compared with baseline, significant
reductions were observed in sleep onset latency (approxi-
mately 14min, 𝑃 < .01), wake after sleep onset (approxi-
mately 15min, 𝑃 = .03), and REM latency (approximately
24min 𝑡(29) = 0.01), and significant increases were found
in total sleep time (approximately 24min, 𝑡(29) = 0.02)
and sleep efficiency (approximately 7%, 𝑡(29) = 0.002) in
the postexercise evaluation. The percentage of REM sleep
increased significantly (2.5%, 𝑡(29) = 0.04), and the latency
of Stage 2 (approximately 13min, 𝑃 = .01) and latency of
Stages 3 and 4 decreased significantly (approximately 22min,
𝑃 = .02) (Table 2).
3.4. Subjective Scales. Subjective sleep rating on the Pitts-
burgh Sleep Quality Index (PSQI) revealed significant
improvement on the subjective sleep duration (approximately
1 h, 𝑡(29) < 0.001) and a significant reduction in sleep
onset latency (24min, 𝑃 = .005) following exercise training
compared with preintervention. The global score on the
PSQI was reduced significantly (approximately 40%, 𝑡(29) <
.0001) after the exercise intervention. The Beck Depression
Inventory score decreased significantly after exercise training
(approximately 30%, 𝑡(29) = 0.04) (Table 3).
3.5. Immune Profile. We observed a reduction in plasma
cortisol concentrations after exercise training (13.7 ± 5 to
10.6 ± 4 𝜇g/dL, 𝑃 = .02). Plasma apolipoprotein A increased
(139.2 ± 26 to 153.9 ± 24mg/dL, 𝑃 < .001), and erythrocytes
(4.8 ± 0.4 to 4.6 ± 0.4 106/mm3, 𝑃 = .02), total leukocytes
(6.8±1 to 5.7±2mil/mm3,𝑃 < .001), monocytes (0.39±0.2 to
0.26±0.1mil/mm3,𝑃 < .001), and typical lymphocytes (2.1±
0.7 to 1.7 ± 0.5mil/mm3, 𝑃 < .001) decreased significantly
after the intervention. We also observed significant decreases
in the CD4 (938.8 ± 381 to 778.9 ± 324mm3, 𝑃 < .001) and
CD8 counts (572.2 ± 265 to 434.1 ± 197mm3, 𝑃 < .0010)
(Table 4).
3.6. Correlation of Immunity and Cortisol with Sleep Data.
Significant correlations between the decrease in cortisol and
increases in polysomnographic measures of total sleep time
(𝑟 = −0.50,𝑃 < .05) and REM sleep (𝑟 = −0.47,𝑃 < .05) were
observed. There were no significant correlations between
changes in cortisol or immunity measures and changes in
subjective or objective sleep data.
4. Discussion
The purpose of this study was to investigate the effects of
exercise training on sleep, depression symptoms, immunity,
and cortisol levels of patients with chronic primary insomnia.
The results showed significant improvements in objective and
subjective sleep and a reduction in depression symptoms after
exercise training. Moreover, there were decreases in plasma
cortisol levels and changes in the immunologic parameters,
which were correlated with some of the sleep improvements.
The results are consistent with previous research showing
the benefits of exercise training on sleep and depression
symptoms among patients with chronic primary insomnia
[12, 14, 15].
It has been suggested that persistent hyperarousal at
autonomous, emotional, cognitive, or neurobiological levels
may be the decisive factor in the development and persistence
of chronic primary insomnia [26–28]. This pathway could
be attenuated by well-established anxiety-reducing effects of
exercise [29].
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Table 3: Subjective scales on baseline and postexercise evaluations.
Variable Baseline (𝑁 = 21) After exercise (𝑁 = 21) 𝑃
PSQI (score) 11.2 ± 3 6.8 ± 2 .001
∗PSQI-SOL (min) 46.5 ± 22 22.0 ± 10# .005
PSQI-SE (%) 75.3 ± 29 81.8 ± 17 Ns
PSQI-TST (h) 4.6 ± 2 6.3 ± 2 .001
BDI (score) 9.3 ± 3 6.5 ± 5 .04
Paired Student’s 𝑡-test or ∗Wilcoxon matched pairs test, significant results, 𝑃 < .05; #𝑛 = 20; data are expressed as mean ± SD. PSQI: Pittsburgh Sleep Quality
Index; BDI: Beck Depression Inventory.
Table 4: Cortisol and immune profile of volunteers on the baseline and after exercise.
Variable Baseline (𝑁 = 21) After exercise (𝑁 = 21) 𝑃
Cortisol (𝜇g/dL) 13.7 ± 5 10.6 ± 4 .02
CD4 (mm3) 938.8 ± 381 778.9 ± 324 <.001
CD8 (mm3) 572.2 ± 265 434.1 ± 197 <.001
CD4 : CD8 1.77 ± 0.6 1.9 ± 0.7 ns
C-reactive protein (mg/dL) 0.22 ± 0.2 0.19 ± 0.1 ns
Apolipoprotein A (mg/dL) 139.2 ± 26 153.9 ± 24 <.001
Apolipoprotein B (mg/dL) 98.1 ± 26 94.4 ± 21 ns
Immunoglobulin A (mg/dL) 259.6 ± 123 262.6 ± 103 ns
Hematocrit (%) 42.0 ± 4 41.7 ± 4 ns
Erythrocytes (106/mm3) 4.8 ± 0.4 4.6 ± 0.4 .02
Hemoglobin (g/dL) 14.0 ± 1 13.7 ± 1 ns
Total leukocytes (mil/mm3) 6.8 ± 1 5.7 ± 2 <.001
Neutrophils (mil/mm3) 4.1 ± 1 3.6 ± 1 ns
Monocytes (mil/mm3) 0.39 ± 0.2 0.26 ± 0.1 <.001
Typical lymphocytes (mil/mm3) 2.1 ± 0.7 1.7 ± 0.5 <.001
Eosinophils (mil/mm3) 0.16 ± 0.1 0.14 ± 0.1 ns
Basophils (mil/mm3) 0.05 ± 0.02 0.04 ± 0.02 ns
Platelets (mil/mm3) 271.6 ± 66 276 ± 63 ns
Wilcoxon matched pairs test, significant results, 𝑃 < .05; data are expressed as mean ± SD.
Among the factors discussed with regard to chronic
primary insomnia have been increases in the production of
cortisol [26] and an increase in immune system indicators,
such as interleukin-6, during the daytime [30] and nighttime
[31].
Exercise trainingmight be a particularly helpful nonphar-
macological stimulus for controlling metabolic regulation
and immune function and improving sleep [32]. There is
abundant evidence that exercise promotes immune function
[33–36]. We recently demonstrated that acute and chronic
exercise (aerobic and/or resistance exercise) improves the
metabolic profile and quality of sleep in elderly people [37,
38]. In the present study, our data showed that chronic
exercise also induced positive effects on the immune system
and sleep in patients with chronic primary insomnia.
We found a significant reduction in CD4 and CD8 counts
and a trend toward a reduction in the ratio of CD4 : CD8.
Similar results were found by Unal et al. [39]: the authors
observed a decrease in CD4 cells in sedentarymale university
students after 8 weeks of moderate exercise training. The
minor changes in CD4 and CD8 counts in the present study
were associatedwith the anti-inflammatory response induced
by chronic exercise [40].
We also found a parallel decrease in monocytes and
basophils after exercise. These data corroborate those found
by Kennedy et al. [41] and Michishita et al. [42] in animals
and humans, respectively.
ApoA is a surrogate marker for HDL-C and has been
measured in recent prospective epidemiological studies [43].
Increasing theHDL-C level by 1mg/dLmay reduce the risk of
cardiovascular disease by 2% to 3% [44].This result is consis-
tent with the concept of the beneficial role of HDL-C, which
is based on free cholesterol efflux from macrophages out of
the vessel wall. Of these, the ABCA1 transporter system is the
most efficient, responsible for over 50% of cholesterol efflux
from macrophages to poorly lipidated ApoA. Mature HDL-
C also transfers esterified cholesterol to other lipoproteins
via the enzyme cholesterol ester transporter protein (CETP),
increasing the efficiency of the system [45].
There were some notable limitations of the present study.
First, the sample size was small, which resulted in limited
statistical power.
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Second, without a control treatment, it cannot be ascer-
tained whether the results were influenced by a number of
potential confounding variables associated with participating
in the study, including the demand or expectancy effects asso-
ciated with volunteering for an exercise study for insomnia,
the social interaction between the participants and staff, and
spontaneous remission. Moreover, the exercise regimen was
performed in front of large windows with a beautiful view
of the city, so the results might be partially explained by
increased exposure to bright light, which can have sleep- and
mood-promoting effects. Also, because interim data were not
assessed, it is unclear how long the intervention must be to
produce these effects. Research staff also were not blinded
to treatment, which could have led to further biases towards
positive results.
Another limitation was the large age range of participants
(ages 30–55 y), which could have contributed to greater
variability in sleep. However, since this was a within-subjects
design, this was less of a confound.
Notwithstanding these limitations, the results suggest
that long-term moderate-intensity aerobic exercise improves
the immunological profile, increases apolipoprotein A, and
promotes anti-inflammatory and antiatherogenic changes.
The data can provide some insight into sleep quality in
patients with chronic primary insomnia, and perhaps some of
the improvement in immunology and inflammation caused
by the improvements in sleep after exercise could improve
sleep quality and minimize some of the impairment associ-
ated with chronic primary insomnia.
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